Emergence of hepatitis C virus resistance associated variants in patients failing direct acting antivirals by ultra-deep sequencing

被引：0

作者：

Nguyen, T. ^{[1
,2
]}

Akhavan, S. ^{[3
]}

Caby, F. ^{[4
]}

Bonyhay, L. ^{[5
]}

Larrouy, L. ^{[6
]}

Gervais, A. ^{[7
]}

Lebray, P. ^{[5
]}

Poynard, T. ^{[8
]}

Calmus, Y. ^{[9
]}

Simon, A. ^{[10
]}

Valantin, M. -A. ^{[4
]}

Calvez, V. ^{[1
,2
]}

Marcelin, A. -G. ^{[1
,2
]}

Todesco, E. ^{[1
,2
]}

机构：

[1] Inst Pierre Louis Epidemiol, Paris, France

[2] UPMC Univ Paris 06, Sorbonne Univ, Paris, France

[3] Hop La Pitie Salpetriere, AP HP, Dept Virol, Paris, France

[4] Hop La Pitie Salpetriere, AP HP, Infect Dis Dept, Paris, France

[5] Hop La Pitie Salpetriere, Serv Hepatogastroenterol, Paris, France

[6] Univ Paris Diderot, Hop Bichat, Sorbonne Paris Cite, Lab Virol,AP HP,INSERM,IAME,UMR 1137, Paris, France

[7] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France

[8] Univ Paris 06, Grp Hosp Pitie Salpetriere, Inst Cardiometab & Nutr ICAN, France Sorbonne Univ,UPMC,AP HP,INSERM,UMR S 938, Paris, France

[9] UPMC Paris VI, Hop Pitie Salpetriere, AP HP, Unite Med Transplantat Hepat,Hepatogastroenterol, Blvd Hop, Paris, France

[10] Hop La Pitie Salpetriere, AP HP, Dept Med Interne & Immunol Clin, Paris, France

来源：

JOURNAL OF HEPATOLOGY | 2018年 / 68卷

关键词：

D O I：

10.1016/S0168-8278(18)30751-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

THU-310

引用

页码：S268 / S268

页数：1

共 50 条

[41] Are direct-acting antivirals against hepatitis C virus infection not associated with the recurrence of hepatocellular carcinoma?
Ogawa, Masahiro
Kanda, Tatsuo
Moriyama, Mitsuhiko
HEPATOBILIARY SURGERY AND NUTRITION, 2019, 8 (04) : 423 - 425
[42] Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues
Feld, Jordan J.
CURRENT DRUG TARGETS, 2017, 18 (07) : 851 - 862
[43] RISK OF HEPATOCARCINOGENESIS AFTER ERADICATION OF HEPATITIS C VIRUS BY DIRECT ACTING ANTIVIRALS
Kawaguchi, Yasunori
Otsuka, Taiga
Yoshioka, Wataru
Noge, Shotaro
Takahashi, Hirokazu
Eguchi, Yuichiro
Ozaki, Iwata
Okada, Michiaki
Yanagita, Kimihiko
Kohira, Toshikazu
Ide, Yasushi
Yasutake, Tsutomu
Kawasoe, Hiroaki
Mizuta, Toshihiko
GASTROENTEROLOGY, 2017, 152 (05) : S1099 - S1099
[44] Prevalence and Factors Related to Natural Resistance-Associated Substitutions to Direct-Acting Antivirals in Patients with Genotype 1 Hepatitis C Virus Infection
Esposito, Isabella
Marciano, Sebastian
Haddad, Leila
Galdame, Omar
Franco, Alejandra
Gadano, Adrian
Flichman, Diego
Trinks, Julieta
VIRUSES-BASEL, 2019, 11 (01):
[45] Detection of Hepatitis C Virus Resistant Mutants in the era of Direct Acting Antivirals
Goncalves Rossi, Livia Maria
Rahal, Paula
AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2014, 10 (04) : 179 - 183
[46] Is There a Role for Ribavirin in the Era of Hepatitis C Virus Direct-Acting Antivirals?
Feld, Jordan J.
GASTROENTEROLOGY, 2012, 142 (06) : 1356 - 1359
[47] The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
Chinchilla-Lopez, Paulina
Qi, Xingshun
Yoshida, Eric M.
Mendez-Sanchez, Nahum
ANNALS OF HEPATOLOGY, 2017, 16 (03) : 328 - 330
[48] Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
Jimenez-Perez, Miguel
Gonzalez-Grande, Rocio
Espana Contreras, Pilar
Pinazo Martinez, Isabel
de la Cruz Lombardo, Jesus
Olmedo Martin, Raul
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (29) : 6573 - 6581
[49] Impact of hepatitis C virus direct acting antivirals on hepatocellular carcinoma evolution
Pol, Stanislas
Lam, Laurent
Mouliade, Charlotte
Carrat, Fabrice
JOURNAL OF HEPATOLOGY, 2024, 80 : S733 - S733
[50] Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
Miguel Jiménez-Pérez
Rocío González-Grande
Pilar Espa?a Contreras
Isabel Pinazo Martínez
Jesús de la Cruz Lombardo
Raúl Olmedo Martín
World Journal of Gastroenterology, 2016, 22 (29) : 6573 - 6581

← 1 2 3 4 5 →